Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Latest
  • Genetic reprogramming – the cellular machinery of yeast to create factories that convert sugars and amino acids into plant-based drugs

Fungi to save astronauts from ionizing space radiations

Recent studies show certain Microbiota treatments are backfiring!

Genetic reprogramming – the cellular machinery of yeast to create factories that convert sugars and amino acids  into plant-based drugs
  • BiotechToday
  • Latest
  • World

Genetic reprogramming – the cellular machinery of yeast to create factories that convert sugars and amino acids into plant-based drugs

bioxone September 7, 2020September 7, 2020

–Sheyashree Mondal, Amity University Kolkata

Plants have always been used to cure ailments by chewing, brewed or rubbed on body. Pharmaceutical companies import these plants from specialized farms and extract their active chemical compounds to produce drugs like scopolamine, atropine.

The factory-floor reprogramming of yeast has been carried out by the first author of the article, Dr. Prashanth Srinivasan. Each of the yeast organelles are workstation on an assembly line. Nucleus being the control centre. Electrons are used by cells to clasp or release molecules on the assembly line, and Srinivasan used them to make the products he desired– a family of complex chemical compounds called tropane alkaloids.

The team has spent three years making 34 genetic modifications to the yeast’s DNA to control every step in the chemical assembly process of tropane alkaloids. Their approach is called metabolic engineering, it is a more precise form of biotechnology in which genetic reprogramming uses or modifies naturally-occurring cellular processes to manufacture products to meet human needs.

“Plants are the world’s best chemists; we want to recapitulate their unique and useful chemistries in domesticated microbes to build complex molecules inspired by the natural world but tailored to better meet human needs.” Said Christina D. Smolke.

Source: Biosynthesis of medicinal tropane alkaloids in yeast, Prashanth Srinivasan and Christina D. Smolke, 2 September 2020, Nature.
DOI: 10.1038/s41586-020-2650-9

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged GM plant drug development tropane alkaloids Yeast

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • World

Recent studies show certain Microbiota treatments are backfiring!

bioxone September 7, 2020

–Raddur Samaddar, Amity University Kolkata Hypoxia is the talk of the town now, especially with the advent of COVID-19, curing of patients with severe levels of infection, escalating to respiratory problems, with oxygen-induced treatment is a major form of supportive care. Scientists have come up with a study that provides information on gut microbiota and […]

Related Post

  • BiotechToday
  • World

Dengue, Chikungunya, Zika and COVID-19? A rare mismatch

bioxone October 3, 2020October 2, 2020

Raddur Samaddar, Team bioXone The pandemic is going about its length and breadth, in India, we have 9,43,990 active cases as of 2nd October 2020. The serological activity and also the cross-reactivity of the diseases are a major concern at this moment. A commercial SARS-CoV-2 ELISA test was used for patients diagnosed as Dengue, Zika, […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Witnessing rays of hope as the first Ebola treatment wins approval by FDA

bioxone October 19, 2020October 19, 2020

Surupa Chakraborty, Amity University Kolkata The U.S. Food and Drug Administration recently approved Inmazeb, a potent treatment involving a cocktail of three lab-made monoclonal antibodies (atoltivimab, maftivimab, and odesivimab-ebgn) to fight against Ebola, one of the world’s deadliest diseases known so far. Inmazeb targets the glycoprotein, which latches onto the cell surface receptors and fuses […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • World

Recent studies show certain Microbiota treatments are backfiring!

bioxone September 7, 2020September 7, 2020

–Raddur Samaddar, Amity University Kolkata Hypoxia is the talk of the town now, especially with the advent of COVID-19, curing of patients with severe levels of infection, escalating to respiratory problems, with oxygen-induced treatment is a major form of supportive care. Scientists have come up with a study that provides information on gut microbiota and […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy